Internal Server Error

HemaSense - About the company

HemaSense is an unfunded company based in Flagstaff (United States), founded in 2024 by Cody Hartman and Benjamin Trapp. It operates as a Developer of solutions for early detection and management of blood-related conditions. HemaSense has not raised any funding yet. The company has 13 active competitors, including 6 that are funded. Its top competitors include companies like Engineering for All, Membio and Beijing Zhizhen Biotechnology.

Company Details

Developer of solutions for early detection and management of blood-related conditions. It offers emaSense a non-invasive device to detect and measure bleeding and accelerate recovery in percutaneous intervention.
Key Metrics
Founded Year
2024
Location
Flagstaff, United States
Stage
Unfunded
Ranked
Employee Count
5 as on Apr 30, 2026
Similar Companies
Sign up to download HemaSense's company profile

HemaSense's funding and investors

HemaSense has not raised any funding rounds yet.

HemaSense's founders and board of directors

Founder? Claim Profile
The founders of HemaSense are Cody Hartman and Benjamin Trapp.
Here are the details of HemaSense's key team members:

HemaSense's employee count trend

HemaSense has 5 employees as of Apr 26. Here is HemaSense's employee count trend over the years:
Employee count trend for HemaSense
lockUncover HemaSense's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

HemaSense's Competitors and alternates

Top competitors of HemaSense include Engineering for All, Membio and Beijing Zhizhen Biotechnology. Here is the list of Top 10 competitors of HemaSense, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Engineering for All
Engineering for All
2016, Yokneam Illit (Israel), Series A
Provider of point of care diagnostic device
$7.4M
44/100
2nd
Logo for Membio
Membio
2018, Kitchener (Canada), Seed
Developer of single-use bioreactors for cell and gene therapies
$280K
40/100
3rd
Logo for Beijing Zhizhen Biotechnology
Beijing Zhizhen Biotechnology
2017, Beijing (China), Series B
Provider of hematology testing instruments, reagents, and services
$17.8M
38/100
4th
Logo for LiteBC
LiteBC
2020, Israel, Funding Raised
Developer of smart devices for monitoring blood cells within the body
-
36/100
5th
Logo for CIMON Medical
CIMON Medical
2018, Trondheim (Norway), Seed
Developer of a patented device for monitoring blood flow for early diagnosis
$6.81M
35/100
6th
Logo for Sphere Medical
Sphere Medical
2002, Cambridge (United Kingdom), Deadpooled
Monitoring devices for use in the ICU and OR
$11.9M
33/100
7th
Logo for Kalium Health
Kalium Health
2018, Cambridge (United Kingdom), Seed
Developer of device for monitoring blood potassium
$1.22M
33/100
8th
Logo for SciLogica
SciLogica
2019, Denver (United States), Series A
Developer of a continuous blood parameter monitoring platform for critical care healthcare
$8.16M
-
32/100
9th
Logo for HemaSense
HemaSense
2024, Flagstaff (United States), Unfunded
Developer of solutions for early detection and management of blood-related conditions
-
-
28/100
10th
Logo for ToxCO
ToxCO
2019, Maidstone (United Kingdom), Unfunded
Developer of a breath monitoring device to detect carbon monoxide poisoning
-
-
24/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on HemaSense's competitors? Click here to see the top ones

HemaSense's Investments and acquisitions

HemaSense has made no investments or acquisitions yet.

News related to HemaSense

Media has covered HemaSense for 1 event in last 1 year.
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about HemaSense

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford